BrainStorm Cell Therapeutics
BCLI
#10185
Rank
NZ$11.71 M
Marketcap
$2.05
Share price
-6.50%
Change (1 day)
-87.32%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.97

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.05. In 2022 the company made an earnings per share (EPS) of -$1.18 an increase over its 2021 EPS that were of -$1.21.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.97-17.47%
2022-$1.18-2.94%
2021-$1.21-37.04%
2020-$1.931.89%
2019-$1.8951.43%
2018-$1.25159.26%
2017-$0.48-3.57%
2016-$0.50-37.78%
2015-$0.80-33.82%
2014-$1.2136%
2013-$0.8911.11%
2012-$0.8050%
2011-$0.54-50%
2010-$1.07-233.33%
2009$0.80-142.86%
2008-$1.88-65%
2007-$5.36
2005$1.77-108.03%
2004-$22.0413203.07%
2003-$0.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.84-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.17 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.16 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.98-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.52 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA